{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:22:32Z","timestamp":1761862952465},"reference-count":42,"publisher":"Frontiers Media SA","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1734,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1111\/j.1432-2277.2010.01138.x","type":"journal-article","created":{"date-parts":[[2010,8,15]],"date-time":"2010-08-15T20:45:52Z","timestamp":1281905152000},"page":"21-29","source":"Crossref","is-referenced-by-count":15,"title":["Desensitization for renal transplantation: depletion of donor-specific anti-HLA antibodies, preservation of memory antibodies, and clinical risks"],"prefix":"10.3389","volume":"24","author":[{"given":"Natasha M.","family":"Rogers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hooi S.","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svjetlana","family":"Kireta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Tsiopelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg D.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas R.","family":"Brook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gillis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme R.","family":"Russ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Toby","family":"Coates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2010,12,2]]},"reference":[{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"\u201cNatural\u201d human leukocyte antigen antibodies found in nonalloimmunized healthy males","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"A740","DOI":"10.1016\/S0016-5085(03)83737-X","article-title":"Anti-human leukocyte antigen (HLA) antibodies in non-transfused, non-transplanted patients with chronic hepatitis C","volume":"124","author":"El","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB3|cit3","first-page":"71","article-title":"Circulating anti-HLA antibodies in patients with chronic hepatitis C: relation to disease activity","volume":"11","author":"El Aggan","year":"2004","journal-title":"Egypt J Immunol"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.transproceed.2007.05.013","article-title":"Interferon-\u03b1 therapy and anti-human leutkocyte antigen antibodies in hepatitis C virus-positive patient: case report","volume":"39","author":"Cervelli","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/ndt\/13.8.2059","article-title":"Impaired renal graft survival after a positive B-cell flow-cytometry crossmatch","volume":"13","author":"Bittencourt","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1600-6143.2008.02387.x","article-title":"Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss","volume":"8","author":"Eng","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0198-8859(02)00363-4","article-title":"B-Cell crossmatching and kidney allograft outcome in 9031 United States transplant recipients","volume":"63","author":"Mahoney","year":"2002","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB9|cit9","unstructured":"ANZDATA The Queen Elizabeth Hospital"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB10|cit10","volume-title":"National Institutes of Health","author":"U.S. Renal Data System U, Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","year":"2008"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1046\/j.1523-1755.2000.00287.x","article-title":"Effect of waiting time on renal transplant outcome","volume":"58","author":"Meier-Kriesche","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1034\/j.1600-6143.2002.20809.x","article-title":"Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg)","volume":"2","author":"Glotz","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/00007890-200011270-00023","article-title":"A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants","volume":"70","author":"Schweitzer","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.transproceed.2004.12.063","article-title":"Highly successful living donor kidney transplantation after conversion to negative of a previously positive flow-cytometry cross-match by pretransplant plasmapheresis","volume":"37","author":"Thielke","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","article-title":"IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low grade non-Hodgkin\u2019s lymphoma","volume":"90","author":"Maloney","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.humimm.2009.06.010","article-title":"Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools","volume":"70","author":"Eng","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1399-0012.2007.00700.x","article-title":"Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients","volume":"21","author":"Grim","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB18|cit18","unstructured":"ANZDATA Registry Report, Appendix I-II 2008"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB19|cit19","volume-title":"Transplant waiting list","author":"Campbell","year":"2008"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-6143.2009.02785.x","article-title":"Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients","volume":"10","author":"Kamar","year":"2010","journal-title":"Am J Transplant"},{"issue":"suppl 2","key":"10.1111\/j.1432-2277.2010.01138.x-BIB21|cit21","first-page":"564","article-title":"Risk of infection in kidney-transplant recipients treated with rituximab","volume":"9","author":"Tsepepas","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1023\/A:1008389119525","article-title":"Extended rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin\u2019s lymphoma","volume":"10","author":"Piro","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4049\/jimmunol.180.1.361","article-title":"Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice","volume":"180","author":"DiLillo","year":"2008","journal-title":"J Immunol"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4049\/jimmunol.174.2.817","article-title":"Importance of cellular microenvironment and circulatory dynamics of B cell immunotherapy","volume":"174","author":"Gong","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/HAB-2004-13301","article-title":"In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody","volume":"13","author":"Sidner","year":"2004","journal-title":"Hum Antibodies"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB26|cit26","first-page":"867","article-title":"IVIG inhibits cross-match (CMX) positivity and allows successful transplantation in living donor and cadaveric transplant recipients (abstract)","volume":"3","author":"Jordan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1034\/j.1600-6143.2002.20809.x","article-title":"Desensitisation and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg)","volume":"2","author":"Glotz","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0140-6736(89)91672-3","article-title":"Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation","volume":"1","author":"Palmer","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(96)03452-6","article-title":"Prevention of hyperacute rejection by removal of antibodies to HLA immediately before transplantation","volume":"348","author":"Higgins","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/01.TP.0000148732.26761.FA","article-title":"Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitised cross-match positive cadaveric allograft recipients","volume":"79","author":"Lorenz","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB32|cit32","first-page":"696","article-title":"Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantation","volume":"136","author":"Ferrari-Lacraz","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific antibody","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.TP.0000112934.12622.2B","article-title":"Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics","volume":"77","author":"Vieira","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1034\/j.1600-6143.2003.00180.x","article-title":"Overcoming a positive crossmatch in living-donor kidney transplantation","volume":"3","author":"Gloor","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TP.0b013e3181d21e7f","article-title":"Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation","volume":"89","author":"Vo","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.TP.0000128516.82593.47","article-title":"Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation","volume":"78","author":"Gloor","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1034\/j.1600-6143.2001.001003260.x","article-title":"Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody","volume":"1","author":"Salama","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MOT.0b013e3283342712","article-title":"Deciphering antibody-mediated rejection: new insights into mechanisms and treatment","volume":"15","author":"Stegall","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB40|cit40","doi-asserted-by":"crossref","DOI":"10.1007\/s12026-009-8154-1","article-title":"Immunogenetics and immunology in transplantation","author":"Zachary","year":"2010","journal-title":"Immunol Res"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.humimm.2008.06.013","article-title":"Detecting and monitoring human leukocyte antigen-specific antibodies","volume":"69","author":"Zachary","year":"2008","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1432-2277.2010.01138.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1600-6143.2009.02764.x","article-title":"Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody","volume":"9","author":"Locke","year":"2009","journal-title":"Am J Transplant"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2010.01138.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2010.01138.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:37:01Z","timestamp":1641062221000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2010.01138.x"}},"subtitle":["Desensitization for transplantation and memory antibodies"],"short-title":[],"issued":{"date-parts":[[2010,12,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2010.01138.x","relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,2]]}}}